Increased tumor immune dysfunction and rejection (TIDE) scores were detected more frequently in the high-risk group than in the low-risk group (Figure 6B); The results predicted by different software can visually show that immune cells such as B-cell naive and T-cell CD8 + are positively correlated with risk scores. This evidence concerns the gene CD8A and neoplasm.